Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP001229

Drug Information
SynonymsSensorcaine-MPF Spinal; BPBio1_000298; Bupivacaine Carbonate; Prestwick0_000305; DUR-843; Marcaine HCL; DB00297; AKOS001637202; Win 11318; Bucaine; Marcaine; 38396-39-3; 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide; NCGC00178579-02; ( inverted exclamation markA)-bupivacaine; AH 250; EINECS 218-553-3; KBio2_007140; Marcaine Spinal; NSC119660; 2180-92-9; SMR000058218; BRD-A01636364-003-05-2; Bio-0886; Bupivacaina; NCGC00178579-01; DepoBupivacaine; Bupivacaine HCL; AC1L1DRE; Sensorcaine; MolPort-004-955-820; KBio2_002004; Bupivacainum [INN-Latin]; 1-Butyl-2',6'-pipecoloxylidide; HMS2090F12; Spectrum3_000974; MLS001361336; IDI1_000758; LS-2222; C18H28N2O; UNII-Y8335394RO; bupivacaine; LS-109841; 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-; 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide; Sensorcaine-MPF; Win 11318 HCl; NINDS_000758; Anekain; Carbostesin; Bupivacaina [INN-Spanish]; DivK1c_000758; Bupivacaine HCL KIT; 15233-43-9; Prestwick3_000305; AC-2096; Bucaine (TN); SPBio_001558; AB00053674; CHEBI:3215; AC1Q5LX4; KBio2_004572; 2',6'-Pipecoloxylidide, 1-butyl-; (1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide; D07552; Bloqueina; Bupivacaine [INN:BAN]; SPBio_002489; Spectrum4_001098; DL-Bupivacaine; Prestwick2_000305; Prestwick1_000305; CID2474; KST-1A4609; EINECS 253-911-2; Spectrum5_001483; KBioSS_002004; BSPBio_002607; cBupivacaine; Transdur-Bupivacaine; Bupivacaine (INN); CHEMBL1098; Marcaina; C07529; L000695; Bupivacaine Monohydrochloride, Monohydrate; KBio3_001827; Spectrum_001524; Spectrum2_001589; KBioGR_001516; Bupivan; AR-1A0242; 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (+-)-; (+-)-Bupivacaine; BSPBio_000270; dl-1-Butyl-2',6'-pipecoloxylidide; KBio1_000758; Bupivacainum    
Trade NameMarcain; Marcaine; Sensorcaine; Vivacaine    
IndicationAnestheticApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAnesthetics    
CAS NumberCAS 2180-92-9
PubChem Compound IDCID 2474.    
PubChem Substance IDSID 9732.    
SuperDrug ATC IDN01BB01;    
SuperDrug CAS ID038396393;    
TargetSodium channelBlocker[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 071810 To Reference
Ref 2Early blockade of injured primary sensory afferents reduces glial cell activation in two rat neuropathic pain models. Neuroscience. 2009 Jun 2;160(4):847-57. Epub 2009 Mar 19. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543